137 results
P
pacientes con COVID-19
I/C
inhibidores de la enzima convertidora de angiotensina, bloqueadores del receptor de angiotensina II, placebo o ningún tratamiento
O
efectos sobre la COVID-19
P
patients with de novo IAs
I/C
systematic review and meta-analysis of existing de novo IA cohorts, initial IAs in the middle cerebral artery
O
de novo IAs
P
mujeres postmenopáusicas
I/C
uso de estrógenos
O
infección del tracto urinario sintomática
P
pacientes sometidos a cirugía
I/C
intervenciones con ejercicio, controlados
O
reducción de la sarcopenia
P
patients with knee osteoarthritis
I/C
offloader knee braces, use of offloader knee braces vs. no use
O
physical function, pain, quality of life, adverse events
P
patients with carious lesions
I/C
stepwise removal technique, complete removal technique
O
pulp exposure, signs and symptoms of pulp disease, restoration failure
P
patients undergoing orthognathic surgery
I/C
long-term antibiotic prophylaxis, short-term antibiotic prophylaxis
O
surgical site infection, hospital stay longer than two days
P
adult patients with generalized anxiety disorder
I/C
vortioxetine, standard psychopharmacological treatment
O
response to treatment, anxious symptoms, nausea
P
patients with polypoidal choroidal vasculopathy
I/C
anti-vascular endothelial growth factor drugs, photodynamic therapy, combination of photodynamic therapy and anti-vascular endothelial growth factor drugs, anti-vascular endothelial growth factor drugs alone
O
incidence of retinal hemorrhage, visual acuity gain, polyp regression, central retinal thickness
P
patients with dry eye
I/C
autologous serum treatment, artificial tear drops
O
adverse effects, quality of life, severity of the pathology, pain, corneal epitheliopathy grade